ByHeart Recalls All Infant Formula Nationwide Amid Botulism Outbreak Investigation
ByHeart has recalled all infant formula nationwide due to an ongoing botulism outbreak. At least 15 babies in 12 states have been sickened and hospitalized since August.
Overview
ByHeart initiated a nationwide recall of all its Whole Nutrition Infant Formula products, including all batches and packaging types, due to an infant botulism outbreak.
At least 15 infants across 12 states have been sickened since August after consuming ByHeart formula, leading to hospitalizations, though no deaths have been reported.
The FDA recommended the expanded recall and is actively investigating 84 cases of infant botulism detected since August, with 15 infants hospitalized.
Parents and caregivers are strongly advised to immediately stop using and safely dispose of any ByHeart infant formula to prevent further illness.
While 13 confirmed cases involved ByHeart formula, investigators have not yet identified a direct link between the formula and all cases, nor other brands.
Analysis
Center-leaning sources cover the ByHeart baby formula recall neutrally, focusing on factual reporting of the event, official statements, and public health information. They present information from both the company and regulatory bodies without editorializing or using loaded language, ensuring a balanced and informative account for readers.
FAQ
ByHeart has voluntarily recalled all lots and packaging types of its Whole Nutrition Infant Formula nationwide due to the ongoing investigation into an infant botulism outbreak.
At least 15 infants across 12 states have been sickened and hospitalized after consuming ByHeart infant formula, with no deaths reported so far.
While 13 confirmed infant botulism cases involved ByHeart formula, investigators have not yet identified a direct causal link between the formula and all cases, and no contamination has been detected in product testing.
Infant botulism symptoms often start with constipation, followed by difficulty feeding (sucking and swallowing), a weak and altered cry, and loss of muscle tone.
The FDA has reported that ByHeart formula accounts for about 1% of U.S. infant formula sales, so this recall is not expected to cause an infant formula shortage for parents and caregivers.
